Thibaut Fourniols - Publications

Size-dependent immunomodulation by MSC secretome: soluble factors target innate pathways, components larger than 100 kDa regulate T cell proliferation.

Journal: Stem cell research & therapy

Published: July 15, 2025

Corrigendum: Mesenchymal stromal cell derived extracellular vesicles as a therapeutic tool: immune regulation, MSC priming, and applications to SLE.

Journal: Frontiers in immunology

Published: March 27, 2024

International Society for Extracellular Vesicles Workshop. QuantitatEVs: multiscale analyses, from bulk to single extracellular vesicle.

Journal: Journal of extracellular biology

Published: February 26, 2024

Mesenchymal stromal cell derived extracellular vesicles as a therapeutic tool: immune regulation, MSC priming, and applications to SLE.

Journal: Frontiers in immunology

Published: December 14, 2023

Surface Modification of Lipid-Based Nanoparticles.

Journal: ACS nano

Published: April 21, 2022

Colorectal cancer inhibition by BET inhibitor JQ1 is MYC-independent and not improved by nanoencapsulation.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: April 21, 2021

Inhibition of colorectal cancer-associated fibroblasts by lipid nanocapsules loaded with acriflavine or paclitaxel.

Journal: International journal of pharmaceutics

Published: February 28, 2020

Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: April 30, 2019

Temozolomide-loaded photopolymerizable PEG-DMA-based hydrogel for the treatment of glioblastoma.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: February 23, 2015